• News
  • SAN DIEGO
  • Finance

ResMed climbs as 2Q report surpasses estimates

San Diego-based respiratory product maker ResMed Inc. posted strong fiscal second-quarter results Thursday, and its shares advanced in after-hours trading.

ResMed (NYSE: RMD) said its net income rose 24 percent over the three months ended Dec. 31, and it said sales in the Americas were particularly strong. The company said customers are shifting to newer products like its S9 sleep apnea devices.

The company said its net income increased to $77.9 million, or 53 cents per share, from $62.9 million, or 42 cents per share, a year ago. Revenue rose 13 percent, to $376.5 million from $332.7 million.

According to FactSet, analysts expected ResMed to report a profit of 52 cents per share on $364.8 million in revenue for the quarter.

Shares of ResMed gained 34 cents to $45.47 during regular trading and advanced $2.03, or 4.5 percent, to $47.50 in late trading. The stock has been trading at all-time highs since August and has gained 65 percent over the last 12 months.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Subscribe Today!